Biotech and Donald Trump: A conversation about what comes next
A conversation between @adamfeuerstein and @matthewherper about what Donald Trump’s reelection could mean for biotech.
Related Articles
From the coolguides community on Reddit: A Cool Guide to Boost your Brainpower
Explore this post and more from the coolguides community
Covid-19, flu, RSV: Vaccine recommendations for fall—and the best time to get them
It’s time to schedule your vaccines for fall. Here are the shots a physician recommends and when you should get them.
Ahold Delhaize’s US ‘cybersecurity issue’ enters week two
Stores still open, but customers report delayed deliveries, invoicing issues, and more at Stop & Shop and others
Hidradenitis Suppurativa-Related Stigmatization Linked to Duration, Itch, Depression
This analysis highlighted links between depression, stigmatization, anxiety, and health- and disease-related variables among individuals with HS in Europe.
Cardinal Health to acquire two more specialty companies
The healthcare products and services company plans to acquire Advanced Diabetes Supply Group and a majority stake in GI Alliance by early 2025.
Johnson & Johnson sues Biden administration over payment terms for 340B hospitals
Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some hospitals that participate in
Esophageal Plaques and Systemic Sclerosis
Esophageal involvement in scleroderma has many possible manifestations, and long-term use of proton-pump inhibitors can increase the risk of candidiasis.
Super-strong magnetic muscles lift 1,000 times their weight with ease
Ulsan National Institute of Science & Technology (UNIST) team in South Korea has developed an innovative magnetic composite artificial muscle.
Stool Metabolites Could Aid in Endometriosis Diagnosis and Therapy
Women with endometriosis—a painful condition with no cure that is a leading cause of infertility—have distinct stool metabolites that could be used for noninvasive diagnoses,…
DOJ sues to block UnitedHealth takeover of home health giant Amedisys
The Department of Justice sued to prevent UnitedHealth Group from buying Amedisys, one of the largest home health and hospice chains